ProPhase Labs (PRPH) Prices 4.17M Share Offering at $0.72/sh

Go back to ProPhase Labs (PRPH) Prices 4.17M Share Offering at $0.72/sh

ProPhase Labs Announces Pricing of Public Offering of Common Stock

November 7, 2024 11:37 PM UTC

GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (ProPhase or the Company), a next-generation biotech, genomics and diagnostics company, today announced the pricing of its underwritten public offering of 4,170,000 shares of common stock. Each share of common stock is being sold at a public offering price of $0.72 per share, for gross proceeds of approximately $3 million, before deducting underwriting discounts, and offering expenses. All of the shares are being offered by the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up... More